Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04742257 · ClinicalTrials.gov registry record · NA
Study Evaluating MyoRegulator® Treatment in Post-Stroke Upper Limb Spasticity
A NA study, sponsored by PathMaker Neurosystems.
- Terminated
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT04742257 is a NA study that was terminated before completion, run by PathMaker Neurosystems. The registered enrollment target is 28 participants.
The verdict
NCT04742257, a NA study, was terminated before completion, sponsored by PathMaker Neurosystems.
- TERMINATED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This is a multi-center, randomized, double-blind (patient and evaluator), sham-controlled study to be conducted in stroke patients with upper-extremity spasticity. The main objectives of this study are to evaluate the performance and safety of the MyoRegulator® device in active- versus sham-treated patients after 5 consecutive days of treatment. The MyoRegulator® device is a non-significant risk (NSR) investigational non-invasive neuromodulation device that uses multi-site direct current (multi-site DCS) stimulation for the treatment of muscle spasticity.
Interventions
- DEVICE MyoRegulator® device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-03-04 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04742257
The ClinicalTrials.gov registry entry for NCT04742257 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PathMaker Neurosystems, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MyoRegulator® device is the first listed.
NCT04742257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04742257 about?
NCT04742257 is a clinical study titled "Study Evaluating MyoRegulator® Treatment in Post-Stroke Upper Limb Spasticity". This is a multi-center, randomized, double-blind (patient and evaluator), sham-controlled study to be conducted in stroke patients with upper-extremity spasticity. The main objectives of this study are to evaluate the performance and safety of the MyoRegulator® device in active- versus sham-treated ...
What is the current status of trial NCT04742257?
This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2022-03-04. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT04742257?
The interventions under investigation include: MyoRegulator® device (DEVICE).
Who is sponsoring clinical trial NCT04742257?
This trial is sponsored by PathMaker Neurosystems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.